Top Buy
| Security | Buy | Sell | Buy (1W) ▲ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Fagron N.V. | 1 | 0 | 0 | 0 | €18.94 | €20.00 | 5.597% |
| TG Therapeutics Inc. | 22 | 4 | 0 | 0 | €15.03 | €28.06 | 86.773% |
| Esperion Therapeutis.Inc. | 15 | 0 | 0 | 0 | €1.99 | €8.55 | 330.179% |
| Adverum Biotechnologies Inc. | 7 | 0 | 0 | 0 | €1.38 | €5.60 | 305.913% |
| ProQR Therapeutics N.V. | 8 | 1 | 0 | 0 | €1.70 | €3.03 | 78.599% |
| Biolife Solutions Inc | 1 | 0 | 0 | 0 | €19.70 | - | - |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €67.72 | €100.00 | 47.667% |
| Rhythm Pharmaceuticals | 15 | 0 | 0 | 0 | €33.00 | €45.98 | 39.333% |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 0 | 0 | €14.91 | €24.13 | 61.859% |
| Dynavax Technologies Corp | 2 | 0 | 0 | 0 | €11.06 | €26.95 | 143.778% |
| Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | €9.59 | - | - |
| EyePoint Pharmaceuticals Inc. | 18 | 1 | 0 | 0 | €9.92 | €27.80 | 180.282% |
| Xeris Biopharma Holdings Inc. | 6 | 0 | 1 | 0 | €2.08 | €4.39 | 111.323% |
| XOMA Corp. | 7 | 0 | 1 | 0 | €22.60 | €68.62 | 203.629% |
| Novavax Inc. | 8 | 1 | 1 | 0 | €13.87 | €27.38 | 97.466% |
| Galmed Pharmaceuticals Ltd. | 9 | 0 | 1 | 0 | €0.35 | €65.08 | 18388.352% |
| Corcept Therapeutics Inc. | 12 | 0 | 1 | 0 | €29.22 | €36.17 | 23.800% |
| X4 Pharmaceuticals, Inc. | 6 | 0 | 1 | 0 | €0.94 | €3.69 | 294.709% |
| Krystal Biotech | 18 | 0 | 1 | 0 | €147.45 | €179.60 | 21.801% |
| Cytokinetics Inc. | 31 | 2 | 1 | 1 | €44.80 | €83.06 | 85.396% |
| Codexis Inc. | 6 | 2 | 1 | 0 | €3.14 | €8.36 | 165.878% |
| Trinity Biotech ADR | 24 | 0 | 1 | 0 | €0.41 | - | - |
| Natural Alternat. | 19 | 1 | 1 | 0 | €5.90 | - | - |
| G1 Therapeutics | 20 | 1 | 3 | 0 | €3.05 | €10.03 | 229.186% |
| Verastem Inc. | 13 | 0 | 4 | 0 | €3.64 | €19.95 | 448.102% |